- Current report filing (8-K)
03 6월 2010 - 3:19AM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
May
27
, 20
1
0
TIENS BIOTECH GROUP (
USA), INC.
(Exact name of registrant as specified
in its charter)
|
|
|
|
|
Delaware
|
|
001-32477
|
|
75-2926439
|
(State or other
jurisdiction
|
|
(Commission File
Number)
|
|
(I.R.S. Employer
|
of incorporation)
|
|
|
|
Identification Number)
|
No.
6,
Yuanquan
Road, Wuqing New-Tech Industrial Park, Tianjin,
China
301700
(Address
of principal executive
offices)
Registrant's telephone number, including
area code:
(86)
22
-
8213-7658
Not
applicable
(Former name or former address, if
changed since last rep
ort.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction
A.2.):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
materials pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.07 Submission of Matters to a Vote of Security Holders
On May
27, 2010, Tiens Biotech Group (USA), Inc. (the “Company”) held its annual
meeting of stockholders (“Annual Meeting”) to vote on the following
matters:
1.
Election of
Directors
All of
the following six nominees were elected to the Company’s Board of Directors, in
accordance with the voting results listed below, to serve for a term of one
year, until the next Annual Meeting and until their successors have been duly
elected and have qualified.
|
|
|
|
|
|
|
|
|
Jinyuan
Li
|
|
67,831,705
|
|
0
|
|
0
|
|
0
|
Manbo
He
|
|
67,831,705
|
|
0
|
|
0
|
|
0
|
Yupeng
Yan
|
|
67,831,705
|
|
0
|
|
0
|
|
0
|
Socorro
Quintero
|
|
67,831,705
|
|
0
|
|
0
|
|
0
|
Howard
Balloch
|
|
67,831,705
|
|
0
|
|
0
|
|
0
|
Gilbert
Raker
|
|
67,831,705
|
|
0
|
|
0
|
|
0
|
2. Ratification
of the Company’s Independent Auditors
Stockholders
ratified the appointment of Crowe Horwath LLP (“Crowe”) as independent auditors
to audit the financial statements of the Company for the 2010 fiscal year, in
accordance with the voting results listed below.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TIENS BIOTECH GROUP (USA),
INC.
|
|
|
|
|
|
Date: May
28, 2010
|
By:
|
/s/ Manbo
He
|
|
|
|
Name:
Manbo He
|
|
|
|
Title:
Chief Financial Officer
|
|
|
|
|
|
Tiens Biotech GR Usa (AMEX:TBV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Tiens Biotech GR Usa (AMEX:TBV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024